Browse the detailed record of transactions filed by Silvestro Stephen L, 首席执行官. Director active across 1 company, notably OptimizeRx Corp. In total, 29 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €515k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 20 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Silvestro Stephen L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Silvestro Stephen L is Directeur Général and Chief Executive Officer at OptimizeRx Corp, listed on XNAS. Across the 27 filings recorded, the sampled filings from 2021-05-19 to 2025-12-23 show EUR 49271 of purchases and EUR 465332 of sales, with Levée d'options as the modal transaction nature.